MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 234 filers reported holding MYRIAD GENETICS INC in Q1 2016. The put-call ratio across all filers is 2.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $75,316,000 | -47.1% | 3,659,647 | -21.4% | 1.33% | -54.8% |
| Q2 2016 | $142,422,000 | -29.6% | 4,654,327 | -13.9% | 2.94% | -22.0% |
| Q1 2016 | $202,259,000 | -27.4% | 5,403,662 | -16.3% | 3.77% | -31.8% |
| Q4 2015 | $278,776,000 | +9.7% | 6,459,139 | -4.8% | 5.53% | +1.4% |
| Q3 2015 | $254,236,000 | +15.3% | 6,783,252 | +4.6% | 5.45% | +27.4% |
| Q2 2015 | $220,467,000 | +7.2% | 6,486,226 | +11.6% | 4.28% | -3.7% |
| Q1 2015 | $205,667,000 | +44.6% | 5,809,799 | +39.1% | 4.45% | +67.8% |
| Q4 2014 | $142,237,000 | +43.4% | 4,176,074 | +62.4% | 2.65% | +31.0% |
| Q3 2014 | $99,201,000 | -10.6% | 2,571,961 | -9.8% | 2.02% | -29.3% |
| Q2 2014 | $110,971,000 | +39.3% | 2,851,267 | +22.4% | 2.86% | +13.3% |
| Q1 2014 | $79,661,000 | +398.0% | 2,329,953 | +205.6% | 2.52% | +418.5% |
| Q4 2013 | $15,995,000 | – | 762,400 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |